RetinaCME
LECTURECME

Noninfectious Uveitis: Moving Beyond Convention for Long-Term Management

Author(s)/Faculty: Thomas A. Albini, MD; Sunil K. Srivastava, MD
Release Date: 4/17/2018Expiration Date: 4/16/2019
Credit Type: CMENumber of Credits: 0.75
Content Type: LectureProvider: Vindico Medical Education
Noninfectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, a timely diagnosis must be provided, and the initiation of an effective management protocol is imperative. Systemic corticosteroids have been the gold standard and an effective front-line therapy for the treatment of noninfectious uveitis, but the side effects associated with their long-term administration warrant the utilization of other therapy options. New nonsteroidal therapies have recently been approved, and several other agents are currently under investigation for the treatment of noninfectious uveitis. For these agents to be incorporated into effective management protocols, it is essential that their optimal use, mechanisms of action, and safety profiles are understood and considered. In this CME activity, experts in the field provide guidance for the diagnosis and management of noninfectious uveitis, as well as evaluate approved and emerging therapies for the effective long-term treatment of the disease.